Top Institutions in Ophthalmology and Immunology
Institutions were ranked based on their known leadership in ophthalmology and immunology research, particularly in AMD and complement system biology, including clinical trial involvement, translational research, and FDA-approved therapies development.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a world leader in retinal disease research and clinical trials, with extensive expertise in AMD and complement system-targeted therapies. Their collaboration with Harvard Medical School and involvement in pivotal complement inhibition trials position them at the forefront of GA treatment innovation.
Key Differentiators
- Ophthalmology
- Immunology
- Retinal Diseases
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked among the top ophthalmology centers globally, with a robust research portfolio in AMD and complement biology. Their clinical trials infrastructure and basic science research contribute significantly to understanding complement inhibition in GA.
Key Differentiators
- Ophthalmology
- Retina
- Immunology
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a strong history of research in retinal degenerations and immune-mediated eye diseases. Their work on complement system regulation and involvement in early-phase clinical trials of complement inhibitors underscores their leadership in GA research.
Key Differentiators
- Ophthalmology
- Immunology
- Neuro-ophthalmology
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF combines cutting-edge genetic research with clinical ophthalmology, advancing understanding of complement system genetics in AMD and GA. Their translational research bridges molecular mechanisms with novel complement inhibition therapies.
Key Differentiators
- Ophthalmology
- Immunology
- Genetics
-
#5
Moorfields Eye Hospital and UCL Institute of Ophthalmology
London, N/A
Moorfields Eye Hospital is a leading international center for retinal disease research and clinical trials, including complement inhibition strategies for GA. Their integrated clinical and research programs contribute significantly to global advances in AMD treatment.
Key Differentiators
- Ophthalmology
- Immunology
- Clinical Trials
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







